2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4365):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W010255
    Phenylglyoxylic acid
    		99.66%
    Phenylglyoxylic acid (Benzoylformic acid) is a metabolite of ethylbenzene and styrene (EB/S) and can be used as a biomarker of exposure to EB/S in human. Phenylglyoxylic acid can be used as drug intermediate for synthesis of antineoplastic compounds.
    Phenylglyoxylic acid
  • HY-W039199
    5-Methoxy-2-nitro-4-((triisopropylsilyl)oxy)benzoic acid
    		98.82%
    5-Methoxy-2-nitro-4-((triisopropylsilyl)oxy)benzoic acid is a drug intermediate for synthesis of various active compounds.
    5-Methoxy-2-nitro-4-((triisopropylsilyl)oxy)benzoic acid
  • HY-20006
    2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine (hydrochlortde)
    		99.99%
    2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine hydrochlortde is a drug intermediate for synthesis of various active compounds.
    2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine (hydrochlortde)
  • HY-W068212
    16-Hydroxyhexadecanoic acid
    		98.0%
    16-Hydroxyhexadecanoic acid (Juniperic acid) is one of the main monomers of cutin in Vicia faba flower petals. 16-Hydroxyhexadecanoic acid can be used as an internal standard for the measurement of hydroxy and hydroperoxy fatty acids in plasma.
    16-Hydroxyhexadecanoic acid
  • HY-W105804
    Selenocystamine dihydrochloride
    		99.63%
    Selenocystamine dihydrochloride is a selenocysteine derivative that can be used in the synthesis of other active compounds. Selenocystamine dihydrochloride can also induce the aggregation of amphiphilic p-sulfonatocalixarene to form supramolecular nanoparticles.
    Selenocystamine dihydrochloride
  • HY-101541
    Docosahexaenoic acid methyl ester
    		99.82%
    Docosahexaenoic Acid methyl ester is a methylated docosahexaenoic acid analog which can be intercalated into membrane phospholipids without being oxidized or hydrolyzed.
    Docosahexaenoic acid methyl ester
  • HY-Y0100
    N,N'-Dimethyltrimethyleneurea
    		99.91%
    N,N'-Dimethyltrimethyleneurea is an intermediate. N,N'-Dimethyltrimethyleneurea can be used in the preparation of naphthalocyanine compounds (near-infrared absorbing dyes).
    N,N'-Dimethyltrimethyleneurea
  • HY-76136
    1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid
    		99.25%
    1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid (Boc-α-me-dl-pro-oh) is a drug intermediate for synthesis of various active compounds.
    1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid
  • HY-32205
    6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one
    		99.69%
    6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one is a drug intermediate for synthesis of various active compounds.
    6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one
  • HY-Z0629
    Rebamipide impurity 1
    		99.69%
    Rebamipide impurity 1 is an impurity of Rebamipide (HY-B0360).
    Rebamipide impurity 1
  • HY-I0912
    2-(Isopropylthio)aniline hydrochloride
    		99.59%
    2-(Isopropylthio)aniline hydrochloride is a drug intermediate for synthesis of various active compounds.
    2-(Isopropylthio)aniline hydrochloride
  • HY-69142
    2-Chloropyrimidine-5-carboxylic acid
    		99.96%
    2-Chloropyrimidine-5-carboxylic acid is a synthetic intermediate of Vanin-1 inhibitor 2.
    2-Chloropyrimidine-5-carboxylic acid
  • HY-47848
    1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide
    		99.74%
    1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide is a drug intermediate for synthesis of various active compounds.
    1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide
  • HY-78184
    1-Boc-3-benzyl-3-piperidinecarboxylic acid
    		99.96%
    1-Boc-3-benzyl-3-piperidinecarboxylic acid is a drug intermediate for synthesis of various active compounds.
    1-Boc-3-benzyl-3-piperidinecarboxylic acid
  • HY-32208
    tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
    		99.97%
    tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate is a drug intermediate for synthesis of various active compounds.
    tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
  • HY-43029
    (R)-tert-Butyl 3-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
    		99.85%
    (R)-tert-Butyl 3-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate is a drug intermediate for synthesis of various active compounds.
    (R)-tert-Butyl 3-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
  • HY-79096
    Boc-L-phenylalanine
    		99.84%
    Boc-L-phenylalanine is a Boc-protected L-phenylalanine that can be used in the synthesis of other active compounds. Boc-L-phenylalanine is also a capping agent.
    Boc-L-phenylalanine
  • HY-W002798
    Cyclopropanesulfonyl chloride
    		99.89%
    Cyclopropanesulfonyl chloride is an intermediate. Cyclopropanesulfonyl chloride can be used to synthesize Compound 1. Compound 1 has anticancer activity against EGFR triple-mutant tumors.
    Cyclopropanesulfonyl chloride
  • HY-78087
    3-Methylcinnamic acid
    		99.77%
    3-Methylcinnamic acid is a drug intermediate for synthesis of various active compounds.
    3-Methylcinnamic acid
  • HY-42858
    2-Bromo-3-methoxycyclopent-2-enone
    		≥98.0%
    2-Bromo-3-methoxycyclopent-2-enone is a drug intermediate for synthesis of various active compounds.
    2-Bromo-3-methoxycyclopent-2-enone